End points for cardiovascular drug trials in pediatric patients.
Sinaiko
A R
AR
University of Minnesota, Minneapolis 55455, USA. sinai@umn.edu
Lauer
R M
RM
Sanders
S P
SP
D000208:Acute Disease; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002648:Child; D002669:Child Welfare; D002908:Chronic Disease; D002986:Clinical Trials as Topic / Q000592:standards*; D015507:Drugs, Investigational / Q000009:adverse effects*; D023381:Endpoint Determination; D006330:Heart Defects, Congenital / Q000188:drug therapy; D006801:Humans
D015507:Drugs, Investigational